Federal health officials have approved the first lower-cost copy of a biotech drug to reach the U.S. market, a long-awaited milestone that could generate billions in savings for insurers, doctors and patients.
Mar 6, 2015
0
9
India's Patent Office rejected on Thursday US pharmaceutical giant Johnson and Johnson's application to extend its patent on a key tuberculosis treatment, allowing local companies to make cheaper generic versions.
Mar 23, 2023
0
3
US pharmaceutical giant Mylan said Wednesday it has struck a $9.9 billon deal to buy Meda, capping two years of dogged pursuit of the Swedish drugmaker.
Feb 11, 2016
0
4
(HealthDay)—The U.S. Food and Drug Administration on Friday gave its approval to the first generic version of the pain reliever Celebrex (celecoxib).
Jun 3, 2014
0
0
U.S. regulators have approved the first near-copy of Enbrel, drugmaker Amgen's pricey biologic medicine for treating rheumatoid arthritis and other immune system disorders.
Aug 30, 2016
0
1
Researchers from Johns Hopkins University published a new Journal of Marketing article that examines how receiving negative medical results might affect how people choose between generic and brand name drugs.
Apr 19, 2023
0
4
If there's anyone in the United States who can see the future of medicine, it's Dr. Janet Woodcock.
Sep 6, 2019
0
0
(HealthDay)—The antipsychotic medicine ziprasidone (Geodon) and generic versions of the drug can cause a rare, serious skin reaction that can progress to affect other parts of the body, the U.S. Food and Drug Administration ...
Dec 14, 2014
0
0
Analysts say they expect more tie-ups are coming in the generic drug industry in the wake of Teva's mammoth deal for the generic drug business of Allergan.
Jul 27, 2015
0
9
Six generic drug-makers artificially inflated and manipulated prices to reduce competition for an antibiotic and oral diabetes medication, 20 state attorneys general, led by Connecticut, said in a federal lawsuit filed Thursday.
Dec 15, 2016
0
0
